Comparison between Anlon Healthcare IPO and GNG Electronics IPO.
Anlon Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while GNG Electronics IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anlon Healthcare IPO is up to ₹121.03 Cr whereas the issue size of the GNG Electronics IPO is up to ₹460.43 Cr. The final issue price of Anlon Healthcare IPO is ₹91.00 per share and of GNG Electronics IPO is ₹237.00 per share.
| Anlon Healthcare IPO | GNG Electronics IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹86.00 per share | ₹225.00 per share |
| Issue Price (Upper) | ₹91.00 per share | ₹237.00 per share |
| Issue Price (Final) | ₹91.00 per share | ₹237.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 164 shares | 63 shares |
| Fresh Issue Size | 1,33,00,000 shares | 1,68,77,637 shares |
| Fresh Issue Size (Amount) | up to ₹121.03 Cr | up to ₹400.00 Cr |
| OFS Issue Size | 0 shares | 25,50,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹60.44 Cr |
| Issue Size Total | 1,33,00,000 shares | 1,94,27,637 shares |
| Issue Size Total (Amount) | up to ₹121.03 Cr | up to ₹460.43 Cr |
Anlon Healthcare IPO opens on Aug 26, 2025, while GNG Electronics IPO opens on Jul 23, 2025. The closing date of Anlon Healthcare IPO and GNG Electronics IPO is Aug 29, 2025, and Jul 25, 2025, respectively.
| Anlon Healthcare IPO | GNG Electronics IPO | |
|---|---|---|
| Anchor Bid Date | Aug 25, 2025 | Jul 22, 2025 |
| Issue Open | Aug 26, 2025 | Jul 23, 2025 |
| Issue Close | Aug 29, 2025 | Jul 25, 2025 |
| Basis Of Allotment (Tentative) | Sep 01, 2025 | Jul 28, 2025 |
| Initiation of Refunds (Tentative) | Sep 02, 2025 | Jul 29, 2025 |
| Credit of Share (Tentative) | Sep 02, 2025 | Jul 29, 2025 |
| Listing date (Tentative) | Sep 03, 2025 | Jul 30, 2025 |
| Anchor Lockin End date 1 | Oct 01, 2025 | Aug 26, 2025 |
| Anchor Lockin End date 2 | Nov 30, 2025 | Oct 25, 2025 |
Anlon Healthcare IPO P/E ratio is 17.67, as compared to GNG Electronics IPO P/E ratio of 33.35.
| Anlon Healthcare IPO | GNG Electronics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anlon Healthcare Ltd.'s revenue increased by 81% and profit after tax (PAT) rose by 112% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)GNG Electronics Ltd.'s revenue increased by 24% and profit after tax (PAT) rose by 32% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 70.26 | 95.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.68 | 78.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.67 | 33.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹483.68 Cr. | ₹2702.07 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 40.45% | 30.40% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.93% | 17.31% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.73 | 1.95 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.15 | ₹7.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 25.51% | 30.40% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anlon Healthcare IPO Retail Individual Investors (RII) are offered 13,30,000 shares while in GNG Electronics IPO retail investors are offered 13,30,000 shares. Qualified Institutional Buyers (QIB) are offered 99,75,000 shares in Anlon Healthcare IPO and 38,85,528 shares in GNG Electronics IPO.
| Anlon Healthcare IPO | GNG Electronics IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 58,28,290 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 99,75,000 shares | 38,85,528 shares |
| NII | 19,95,000 shares | 29,14,146 shares |
| RII | 13,30,000 shares | 67,99,673 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 1,33,00,000 shares | 1,94,27,637 shares |
Anlon Healthcare IPO subscribed 7.12x in total, whereas GNG Electronics IPO subscribed 150.21x.
| Anlon Healthcare IPO | GNG Electronics IPO | |
|---|---|---|
| QIB (times) | 1.07x | 266.21x |
| NII (times) | 10.61x | 226.44x |
| Big NII (times) | 7.56x | 264.14x |
| Small NII (times) | 16.69x | 182.52x |
| RII (times) | 47.26x | 47.36x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.12x | 150.21x |
